Business Wire

Oxmiq Labs Inc.™: Re-Architecting the GPU Stack: From Atoms to Agents™

5.8.2025 09:01:00 CEST | Business Wire | Press Release

Share

Oxmiq Labs Inc., the all-new GPU software and IP startup founded by one of the world’s top GPU architects and visionaries, Raja Koduri, emerges from stealth after two years of intensive IP development. Raja has assembled a world-class team of GPU and AI architects with over 500 years of combined experience, hundreds of patents, and a collective track record of generating more than $100B in revenue at prior companies.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250805908309/en/

Raja Koduri Founder / CEO Oxmiq Labs Inc.

The Opportunity:

Modern computing has fundamentally shifted toward multimodal experiences where text, audio, video, images, and 3D environments seamlessly interact, establishing GPU architecture as the cornerstone of this transformation. Unlike fixed-function AI accelerators that handle specific tasks, GPUs provide the general-purpose computational flexibility required for these diverse modalities while maintaining deep integration with mainstream operating systems through standardized APIs and unified memory models. This architectural advantage positions GPUs as the essential compute engine for both current applications and the emerging landscape of multimodal AI, where heterogeneous workloads must be processed in harmony.

OXMIQ™'s licensable GPU IP rearchitects the GPU from first principles incorporating breakthrough technologies including nano agents in silicon leveraging RISC-V cores, near-memory and in-memory computing, and light transport. OXMIQ delivers solutions that balance multimodal computing flexibility with the radical performance improvements required for next-generation graphics and AI workloads for its customers.

Software First:

Learning from decades of industry evolution, OXMIQ embraces a Software First strategy that prioritizes developer experience through a comprehensive software stack compatible with bothOXMIQIP-based silicon and third-party GPU and AI accelerator platforms.

OXCapsule™, OXMIQ's unified software ecosystem, abstracts away hardware complexity to provide frictionless deployment across diverse computing platforms, eliminating the configuration challenges that traditionally plague heterogeneous environments.

A flagship component, OXPython™, enables Python-based NVIDIA® CUDA™ AI applications to execute seamlessly on non-NVIDIA hardware without code modification or recompilation. Launching initially on Tenstorrent's AI platform later this year with multiple vendor integrations in progress, OXPython demonstrates OXMIQ's commitment to breaking down hardware silos and accelerating the democratization of high-performance computing across the industry.

“We’re excited to partner with OXMIQ on their OXPython software stack,” said Jim Keller, CEO of Tenstorrent™. “OXPython’s ability to bring Python® workloads for CUDA to AI platforms like Wormhole™ and Blackhole™ is great for developer portability and ecosystem expansion. It aligns with our goal of letting developers open and own their entire AI stack.”

The OXMIQ Breakthrough:

Beyond software, OXMIQ delivers a complete GPU hardware IP stack that powers silicon solutions scaling from Physical AI in edge devices and autonomous robots to enterprise edge infrastructure and zettascale data centers. Their scalable GPU core, OXCORE™, integrates scalar, vector, and tensor compute engines in a modular architecture customizable for specific workloads, enabling nano-agents, native Python acceleration, and compatibility with SIMD/CUDA paradigms.

OXCORE scales seamlessly from single core for compact Physical AI applications to thousands of cores for data centers via the OXQUILT™ chip-let architecture. Through OXQUILT, customers can configure optimal ratios of compute, memory and interconnect for their needs and achieve significant reduction in time to market, R&D and production costs v/s current industry standard methodologies.

Capital Efficiency & Market Traction:

OXMIQ has raised $20 million in seed funding from prominent technology investors, including strategic players in mobile and AI silicon such as MediaTek®, and has recorded its first round of software revenue. With its licensing-first model, OXMIQ avoids the heavy capital requirements of chip startups that depend on expensive EDA tools and physical tape-outs — delivering outstanding capital efficiency.

“OXMIQ has an impressive bold vision and world-class team,” said Lawrence Loh, SVP of MediaTek“The company’s GPU IP and software innovations will drive a new era of compute flexibility across devices – from mobile to automotive to AI on the edge.”

Mihira™:

After co-founding Mihira two years ago with Shobu Yarlagadda and SS Rajamouli, Raja Koduri has transitioned out of day-to-day operations at Mihira to focus full-time on running OXMIQ. Raja now acts as a strategic advisor to Mihira Visual Labs™, which is led by CEO Shobu Yarlagadda. OXMIQ holds a minority stake in Mihira and will continue to support its growth through foundational agentic and GPU IP technologies that power Mihira’s cinematic AI platform.

“Raja’s early contributions to Mihira helped shape our foundational vision of cinematic AI. Now, with OXMIQ, he and his team are building the deep-tech infrastructure that powers our next chapter,” said Shobu Yarlagadda, Co-Founder and CEO of Mihira Visual Labs™, and acclaimed producer of the Baahubali film series. “As we scale Mihira into a global creative platform, we’re thrilled to continue our close collaboration with OXMIQ and integrate their agentic GPU innovations into our storytelling stack.”

To learn more about licensing, investment, or career opportunities visit us on the web at oxmiq.ai.

Trademark Acknowledgments

NVIDIA and CUDA are trademarks or registered trademarks of NVIDIA Corporation in the U.S. and other countries. Python is a registered trademark of the Python Software Foundation. Tenstorrent, Wormhole, and Blackhole are trademarks of Tenstorrent Inc. MediaTek is a registered trademark of MediaTek Inc. All other product names, trademarks, and registered trademarks are property of their respective owners and are used for identification purposes only.

View source version on businesswire.com: https://www.businesswire.com/news/home/20250805908309/en/

Contacts

Media Contact mark.hirsch@oxmiq.ai

(c) 2024 Business Wire, Inc., All rights reserved.

Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

BeOne Presents Compelling Data in Hard-to-Treat Liver and Lung Cancers at ESMO 202624.10.2026 10:15:00 CEST | Press Release

BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new data from multiple differentiated investigational medicines across its priority solid tumor disease areas at the European Society for Medical Oncology (ESMO) Congress 2026 (October 23–27, Madrid). The presentations span gastrointestinal, lung, and breast cancers, and reflect the growing momentum of BeOne’s solid tumor franchise. Mark Lanasa, M.D., Ph.D., Chief Medical Officer, Solid Tumors at BeOne, said: “At ESMO, we are showing how our strategy of matching the right modality to disease biology is translating into meaningful clinical progress. Our GPC3 x 4-1BB bispecific antibody continues to be well tolerated and demonstrates durable activity with longer follow up in patients with heavily pre-treated hepatocellular carcinoma, while the first clinical data from our brain-penetrant PRMT5 inhibitor and CEA-targeting ADC expand our innovation in non-small cell lung cancer. Alongsi

Phase 3 RAINIER Results Supporting Best-in-Class Potential of Povetacicept in IgA Nephropathy Published in the New England Journal of Medicine and Presented at the American Society of Nephrology Kidney Week 202623.10.2026 19:42:00 CEST | Press Release

Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced the publication of Phase 3 RAINIER results for povetacicept in the New England Journal of Medicine (NEJM), presentation of these data at the American Society of Nephrology (ASN) Kidney Week 2026 in Denver, Colorado, and advancement of the povetacicept clinical research program in IgAN. Vertex will also host an investor event during ASN on October 23 at 6:15-7 p.m. MDT (8:15-9 p.m. EDT). Further details are below. Data being presented include a pre-specified Week 36 interim analysis of the ongoing Phase 3 RAINIER trial of povetacicept, an engineered fusion protein and dual inhibitor of the BAFF (B cell activating factor) and APRIL (a proliferation inducing ligand) cytokines, in immunoglobulin A nephropathy (IgAN). RAINIER met its primary endpoint, with povetacicept achieving a 52.0% reduction from baseline in proteinuria at Week 36 and a statistically significant and clinically meaningful 49.8% reduction versus placebo (

Lifezone Metals Confirms Advanced Negotiations with Orion CMC on Kabanga Nickel Project23.10.2026 16:19:00 CEST | Press Release

Lifezone Metals Limited (NYSE: LZM) notes comments made today by Oskar Lewnowski, Founder and Group Chief Executive of Orion Resource Partners, in an interview with Bloomberg Television regarding the Company’s Kabanga Nickel Project in Tanzania. In response to inbound inquiries from media outlets and investors following the interview, the Company can confirm that negotiations with Orion Critical Mineral Consortium (Orion CMC) regarding a significant equity investment into the Kabanga Nickel Project are at an advanced stage. The Orion CMC is a global investment platform launched by Orion Resource Partners in partnership with the U.S. International Development Finance Corporation (DFC) and Abu Dhabi's sovereign investor ADQ. As previously announced, the Company has been running a competitive process, led by Standard Chartered Bank, to secure a strategic investment into the Kabanga Nickel Project. Social Media LinkedIn | X | YouTube About Lifezone Metals Lifezone Metals (NYSE: LZM) is com

BeOne Medicines Reports Sustained Survival Benefit with TEVIMBRA-ZIIHERA Combination in First-Line HER2+ Gastroesophageal Cancer23.10.2026 16:15:00 CEST | Press Release

BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new survival results from the planned second interim analysis (IA2) and final formal analysis of the Phase 3 HERIZON-GEA-01 trial, further confirming the benefit of TEVIMBRA® (tislelizumab) plus ZIIHERA® (zanidatamab) and chemotherapy as first-line treatment for patients with HER2-positive locally advanced or metastatic gastroesophageal adenocarcinoma (GEA). The results will be presented today as a late-breaking abstract during a rapid oral session at the European Society for Medical Oncology (ESMO) Congress 2026 in Madrid, Spain (LBA79). Mark Lanasa, M.D., Ph.D., Chief Medical Officer, Solid Tumors at BeOne, said: “Following the U.S. approval in August, these longer-term data provide further evidence supporting TEVIMBRA plus ZIIHERA and chemotherapy as the new standard of care in all first-line HER2-positive advanced gastroesophageal adenocarcinoma patients, regardless of PD-L1 sta

inDrive and Pony.ai Announce Collaboration to Explore Autonomous Mobility in Kazakhstan Built on NVIDIA Hyperion23.10.2026 15:00:00 CEST | Press Release

inDrive, the global mobility and delivery platform, today announced it has signed a memorandum of understanding (MOU) with NVIDIA and Pony.ai, a global leader in the large-scale commercialization of autonomous driving technology, to explore the future of autonomous ride-hailing. Kazakhstan will serve as the first test market. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261023143469/en/ inDrive partners with Pony.ai and NVIDIA to explore autonomous mobility in Kazakhstan Kazakhstan was chosen first for its regulatory readiness following the creation of the country’s first structured legal framework for driverless transport, as part of its “Year of Digitalization and Artificial Intelligence.” Combined with Kazakhstan’s position as a leading Central Asian economy, this gives the companies a clear basis to assess autonomous ride-hailing in practice. The three companies will evaluate the technical, operational, regulatory and

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye